Kadet Defence Systems Private Limited
Indian deep-tech company developing indigenously built loitering munitions, combat UAVs, and unmanned aerial systems.
Kadet Defence Systems Private Limited is an Indian aerospace company founded in 2011, headquartered in Howrah, West Bengal, with operations in Bengaluru. The company designs, develops, and manufactures indigenously built unmanned aerial systems (UAS) with over 50% Indian content, aligned with the Government of India's Atmanirbhar Bharat initiative. Kadet has delivered over 500 systems to the Indian Ministry of Defence and international partners under the DRDO's Development cum Production Partner (DCPP) model.
Its portfolio spans canister-launched loitering munitions, tactical VTOL UAVs, combat UAVs with standoff capabilities, aerial targets, and counter-UAS systems. The company is India's first to develop and deliver loitering aerial munitions to the Indian Armed Forces, with payloads ranging from 50 grams to 40 kilograms and ranges up to 150 km.
Primary type & automation activities this supplier delivers:
Canister Aerial Loitering Munition (CALM)
Canister-launched loitering munition with RF and satellite guidance, payload up to 40 kg, range up to 150 km.
Contact Kadet Defence Systems Private Limited
WEBSITE
https://kadet-uav.comPHONE
-118050HEADQUARTERS
India
Company Facts
Founded
2011
Primary Role
Manufacturer
Company Size
-
Primary Region
Asia-Pacific
Annual Sales
-
Funding Stage
-
Funding Total
-
Certifications & Memberships
Ollobot's OlloNi SS1 Redefines AI Companion Robots for Emotional Connection
Ollobot's OlloNi SS1 is a new generation of AI companion robots designed to address loneliness and emotional needs in modern households. Unlike earlier models, which were limited in functionality, the SS1 employs proactive interaction and emotional intelligence to provide companionship for various demographics, including the elderly, children, and single professionals. The significance of the OlloNi SS1 lies in its ability to create a sense of presence and emotional support, filling gaps left by traditional communication tools. With the global AI companion market projected to grow from $48 billion in 2026 to $318 billion by 2033, Ollobot's innovative approach positions it at the forefront of this expanding industry. Looking ahead, the evolution of the OlloNi SS1 through over-the-air updates and its integration into family activities will be crucial to its success. As the demand for emotional support in technology increases, Ollobot's focus on familiarity and long-term coexistence may set a new standard for companion robots in the future.
Social-robots Human-robot-interaction Computer-vision Companion-robots Multimodal-ai Ai-robots
BlackBerry's CEO Highlights Robotics as a Rapidly Growing Sector in QNX Software
BlackBerry CEO John Giamatteo announced that robotics is among the fastest-growing sectors within the company's QNX software portfolio during an interview with CNBC. QNX, which is embedded in 275 million vehicles, has a significant backlog of approximately $950 million, with a portion attributed to robotics. The importance of robotics in BlackBerry's strategy is underscored by Giamatteo's remarks on the potential for growth in physical AI applications. He emphasized that the company is focusing on industrial robots, such as robotic forklifts and medical instruments, rather than humanoid robots, indicating a strategic pivot towards sectors with substantial growth opportunities. Looking ahead, BlackBerry's partnership with Nvidia aims to enhance its software capabilities in robotics and industrial applications. Giamatteo expressed enthusiasm for the evolving landscape of robotics, suggesting that the company is well-positioned to capitalize on these advancements. No further timeline was disclosed at the time of publication.
Europe's Robotics Challenge: Should It Develop Its Own 'Airbus of Robots'?
Europe has established itself with leaders like Airbus in aerospace and has a strong presence in various industries. However, as robotics evolves, the question arises: who will manufacture the robots that will work in factories, warehouses, hospitals, and potentially homes in the future? With advancements in AI, computer vision, and sensors, robots are becoming more versatile, moving beyond strictly industrial applications. This shift is significant as robots are transitioning from being solely industrial investments to becoming a new form of workforce. The U.S. is heavily investing in AI and robotics, particularly in humanoids and Physical AI, while China leverages its robust supply chain to dominate the industrial robotics landscape. The competition is not just about showcasing impressive humanoids but mastering the entire value chain, including components, manufacturing, software, and maintenance. Europe is not absent from the robotics scene, boasting recognized manufacturers, excellent laboratories, and specialized companies. Its substantial industrial base across sectors like automotive, aerospace, logistics, energy, healthcare, and food can serve as real-world testing grounds for the next generation of robots. No further timeline was disclosed at the time of publication.
À la une Humanoide IA Robotique Airbus des robots AMR
Generative AI Develops New Bacteriophage Genomes to Combat E. coli Resistance
A generative AI has successfully created novel bacteriophage genomes, leading researchers to identify 16 functional phages. This breakthrough demonstrates a promising AI-driven strategy to address the growing issue of bacterial resistance, particularly against E. coli. The significance of this development lies in its potential to enhance treatment options for infections caused by antibiotic-resistant bacteria. As bacterial resistance continues to rise, innovative solutions like AI-generated bacteriophages could play a crucial role in public health and medical treatments. Looking ahead, the focus will be on further validating the effectiveness of these bacteriophages in clinical settings. No further timeline was disclosed at the time of publication.
New Hypothesis Links Metabolic Syndrome to Cognitive Impairment and Smell Dysfunction
Researchers from the University of Texas Health Science Center at San Antonio and Methodist Hospital proposed a new hypothesis in the journal Frontiers in Neuroscience. They suggest that metabolic syndrome may block the brain's waste removal pathways, leading to olfactory dysfunction, an early symptom of dementia. The study highlights that olfactory dysfunction often precedes memory and motor impairments in neurodegenerative diseases such as Alzheimer's and Parkinson's. The researchers indicate that metabolic syndrome, characterized by conditions like hypertension and obesity, disrupts autonomic balance, causing blood vessels in the nasal cavity to swell and obstruct lymphatic drainage. As the brain's waste disposal function becomes impaired, harmful proteins accumulate near olfactory nerves, resulting in smell dysfunction before cognitive decline. This phenomenon is not only observed in neurodegenerative diseases but also in conditions like depression and traumatic brain injury. No further timeline was disclosed at the time of publication.
Robotics Industry Transitions from Demonstrations to Real-World Applications
The 2026 World Robotics Conference, held in Beijing from August 19 to 23, showcased a significant shift in the robotics industry from mere demonstrations to practical applications. With 373 companies exhibiting over 3,000 products, including more than 150 new releases, the event highlighted the industry's focus on real-world problem-solving. This transition is underscored by the introduction of 'Procurement Day' and the launch of the 'Global Robot Application Exploration Program.' Innovations such as the Tian Gong Omni humanoid robot and the Ant Lingbo 'robot pharmacist' demonstrate the industry's commitment to integrating robotics into everyday tasks, moving beyond the showcase mentality. Looking ahead, industry leaders emphasize the need for large-scale production and the evolution of AI models to meet real-world challenges. The conference signaled a pivotal moment for the robotics sector, indicating a move towards high-quality, scalable solutions that address genuine operational needs.
Robotics Industrial Automation AI Healthcare Robotics Manufacturing Solutions
Integrating Automated Guided Vehicles in Hospitals: Key Considerations and Benefits
Aerocom, specialists in AGV systems, explore the integration of Automated Guided Vehicles (AGVs) into busy hospital environments. They emphasize the importance of thorough planning and staff buy-in to ensure successful deployment. The integration of AGVs can streamline operations, reduce labor costs, and improve patient care, making it a vital technology for modern healthcare facilities. The significance of AGVs in hospitals lies in their ability to enhance operational efficiency and patient safety. By automating routine tasks such as transporting medications and supplies, hospitals can allocate staff resources more effectively, ultimately leading to better patient outcomes. The successful integration of AGVs can also alleviate the burden on healthcare workers, allowing them to focus on critical care responsibilities. Looking ahead, stakeholders should monitor the ongoing developments in AGV technology and its applications in healthcare. As hospitals continue to seek innovative solutions to improve efficiency and patient care, the role of AGVs is expected to expand. No further timeline was disclosed at the time of publication.
Systematic Review of Acoustic Microbots: Fabrication Techniques and Actuation Mechanisms
A systematic review published in the Journal of Field Robotics explores the relationship between fabrication techniques and acoustic actuation mechanisms in acoustic microbots. This study highlights various methods used in the development of these microbots, emphasizing their significance in advancing robotics technology. Understanding the connection between fabrication and actuation is crucial for enhancing the performance and capabilities of acoustic microbots. The findings of this review could lead to improved designs and applications in fields such as medical devices and environmental monitoring, where precision and efficiency are paramount. Future research should focus on integrating innovative fabrication methods with advanced acoustic actuation systems to unlock new functionalities in microbot technology. No further timeline was disclosed at the time of publication.
SURVEY ARTICLE
Travere Therapeutics Sees Surge in Sales Following FILSPARI Approval for FSGS
On April 13, 2026, the FDA granted Travere Therapeutics full approval for FILSPARI, a treatment for focal segmental glomerulosclerosis (FSGS). This marked the drug's second full approval, following a previous clearance for IgA nephropathy in 2023. The approval is significant for patients aged 8 and older with specific subtypes of FSGS, as it offers a new FDA-approved option for a previously underserved condition. The approval is crucial as FSGS can lead to kidney failure, and patients have historically relied on off-label therapies. Travere's Chief Executive Eric Dube emphasized the milestone for FSGS patients, while industry leaders noted the life-changing potential of the drug. Following the approval, Travere reported substantial sales growth, with FILSPARI's U.S. net product sales reaching $105.2 million in Q1 2026, an 88% increase from the previous year, and $141.1 million in Q2 2026, a 96% year-over-year rise. Looking ahead, Travere's first-half 2026 sales totaled $246.2 million, indicating strong market demand for FILSPARI. The company also reported its first quarter of non-GAAP profitability. No further timeline was disclosed at the time of publication.
Business Financials & Investments armistice capital biotech investing biotech stocks civorebrutinib
University of Twente Develops Magnetic-Controlled Capsule Robot for Medication Injection
Researchers at the University of Twente have developed a 10mm capsule robot capable of injecting medication into tissue using magnetic control. This innovative device operates without wires or battery-powered motors, relying instead on an external magnet and a thermally triggered mechanism. The technology, known as Thermally Triggered Magnetic Springs (TTMS), allows for precise delivery of medication, overcoming the limitations of traditional oral drug delivery methods. The significance of this advancement lies in its potential to enhance drug delivery efficiency. Current oral medication capsules often face barriers in the gastrointestinal tract, resulting in low delivery efficiency. The TTMS technology enables targeted drug delivery by utilizing a magnetic spring mechanism that can exert Newton-level forces at the millimeter scale, addressing the challenges of penetrating physiological barriers. Looking ahead, the researchers emphasize the importance of further development and testing of this capsule robot. The TTMS mechanism's ability to control the release of stored energy through temperature changes presents a promising avenue for improving therapeutic applications. No further timeline was disclosed at the time of publication.
Capsule Robots Drug Delivery Medical Robotics Magnetic Navigation
